Concepedia

Mark Kaminski

MK

Statistics

Publications

137

Citations

13.6K

H-Index

57

Active since

1985

Affiliations

University of Michigan(Current)

Memorial Sloan Kettering Cancer Center

The University of Texas MD Anderson Cancer Center

City Of Hope National Medical Center

Fox Chase Cancer Center

Mark Kaminski is an author at University of Michigan specializing in oncology, medicine, and hematologic oncology.

Publications per year

1985–2023

137

Publications

137

An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era

Zheng Zhou, Laurie H. Sehn, Alfred Rademaker et al. · Blood · 2013 · 953 citations

Medicine, Hematology, Oncology +14

Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial

Steven M. Horwitz, Owen A. O’Connor, Barbara Pro et al. · The Lancet · 2018 · 726 citations · Full text

Medicine, Hematology, Oncology +12

<sup>131</sup>I-Tositumomab Therapy as Initial Treatment for Follicular Lymphoma

Mark Kaminski, Melissa Tuck, Judith Estes et al. · New England Journal of Medicine · 2005 · 715 citations · Full text

Medicine, Hematology, Oncology +15

Pivotal Study of Iodine I 131 Tositumomab for Chemotherapy-Refractory Low-Grade or Transformed Low-Grade B-Cell Non-Hodgkin’s Lymphomas

Mark Kaminski, Andrew D. Zelenetz, Oliver W. Press et al. · Journal of Clinical Oncology · 2001 · 586 citations

Medicine, Oncology, Pharmacology +15

Radioimmunotherapy of B-Cell Lymphoma with [<sup>131</sup>I]Anti-B1 (Anti-CD20) Antibody

Mark Kaminski, Kenneth Zasadny, Isaac R. Francis et al. · New England Journal of Medicine · 1993 · 550 citations · Full text

Medicine, Hematology, Oncology +17

1–5 of 137